Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

BACKGROUND: Immunomodulatory therapy (IMT) is often considered for systemic treatment of non-infectious uveitis (NIU). During the evolving coronavirus disease-2019 (COVID-19) pandemic, given the concerns related to IMT and the increased risk of infections, an urgent need for guidance on the manageme...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Ophthalmol
Autori principali: Agrawal, Rupesh, Testi, Ilaria, Lee, Cecilia S, Tsui, Edmund, Blazes, Marian, Thorne, Jennifer E, Okada, Annabelle A, Smith, Justine R, McCluskey, Peter J, Kempen, John H, Tappeiner, Christoph, Agarwal, Manisha, Bodaghi, Bahram, Nguyen, Quan Dong, Gupta, Vishali, De Smet, Marc D, Zierhut, Manfred, Pavesio, Carlos
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Clinical Science
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313529/
https://ncbi.nlm.nih.gov/pubmed/32586933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316776
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi